News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nextpower highlights growth opportunity beyond solar trackers, targeting higher-margin businesses.
  • Company reports a backlog exceeding $5.5 billion.
  • Management raised guidance and reported improving gross margins.
  • Firm plans to monetize storage, eBOS, and power-conversion platforms.
  • Risks include rising operating costs, execution on new segments, and sector cyclicality.
  • Analysts present a tradeable long thesis with defined entry, stop, and target levels.

Latest Articles

Former Mossad Chief, Yossi Cohen, Strategic Advisor to SoftBank, Joins Quantum X Labs as President of Scientific Advisory Board

Former Mossad Chief, Yossi Cohen, Strategic Advisor to SoftBank, Joins Quantum X Labs as President of Scientific Advisory Board

Quantum X Labs appointed Yossi Cohen, former Mossad Director and strategic advisor to SoftBank, as President of its Scientific Advisory Board. Cohen's extensive background in national security and technology investment will guide QXL's development in quantum computing, sensing, and cybersecurity, with a focus on defense, aerospace, and critical inf…

ZenaTech Closes 29th Drone as a Service Acquisition Adding Solar and Railroad Customers with Georgia-based U.S. Land Surveying Company Holding Licenses in 17 States

ZenaTech Closes 29th Drone as a Service Acquisition Adding Solar and Railroad Customers with Georgia-based U.S. Land Surveying Company Holding Licenses in 17 States

ZenaTech, a Nasdaq-listed AI drone and Drone as a Service provider, completed its 29th acquisition by purchasing Merritt Paul Land Surveying, a Georgia-based firm licensed in 17 states. This acquisition deepens ZenaTech's capabilities in utility-scale solar and transportation surveying services, sectors experiencing high growth in drone-based inspe…

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

BioVie Inc. announced positive topline results from its Phase 2 ADDRESS-LC trial evaluating bezisterim, an oral drug candidate targeting neurological symptoms of Long COVID. The drug demonstrated statistically significant benefits in patient subgroups with high baseline fatigue, cognitive impairment, and post-exertional malaise, showing advantage o…

FTI Consulting and Compass Lexecon Lead Lexology Index Consulting Experts List for Eleventh Consecutive Year

FTI Consulting and Compass Lexecon Lead Lexology Index Consulting Experts List for Eleventh Consecutive Year

FTI Consulting, Inc. and its Compass Lexecon subsidiary have been recognized as the leaders in the Lexology Index Consulting Experts list for the eleventh consecutive year, with 127 global professionals honored. The recognition covers expertise across multiple sectors including construction advisory, digital forensics, financial advisory, valuation…

B2Gold's Prepay Clearout: A Setup for a Cash-Flow Rebound

B2Gold's Prepay Clearout: A Setup for a Cash-Flow Rebound

B2Gold (BTG) has cleaned up a major balance-sheet overhang and is positioned for a working-capital and cash-flow inflection as regional projects ramp. The shares are offering a defined-risk entry with upside to $6.25 if the company's operational normalisation and $325M financing tailwinds translate into tangible free cash generation.

BingX Expands from Crypto Exchange to Unified Multi-Asset Trading Platform

BingX Expands from Crypto Exchange to Unified Multi-Asset Trading Platform

BingX announced a strategic shift from a crypto-native exchange to a multi-asset trading platform that merges digital and traditional financial markets. The company says the move will connect crypto, stocks, forex, indices and commodities within a single interface supported by AI-driven tools, TradingView charting, deep liquidity, and reliability m…

Anfield Energy Receives Colorado DRMS Completeness Determination and Staff Recommendation for Approval of JD-8 Mine Permit; Board Hearing Set for October 14-15, 2026

Anfield Energy Receives Colorado DRMS Completeness Determination and Staff Recommendation for Approval of JD-8 Mine Permit; Board Hearing Set for October 14-15, 2026

Anfield Energy's subsidiary Highbury Resources has received a completeness determination and recommendation for approval from Colorado DRMS on the JD-8 mine reclamation permit application. A formal board hearing is scheduled for October 14-15, 2026, marking a significant regulatory milestone. The company targets restarting uranium and vanadium prod…

Aeluma Executes Strategic Agreement with Sumitomo Chemical Advanced Technologies for Wafer Production for AI Datacom

Aeluma Executes Strategic Agreement with Sumitomo Chemical Advanced Technologies for Wafer Production for AI Datacom

Aeluma, Inc. has entered into a strategic agreement with Sumitomo Chemical Advanced Technologies (SCAT) to accelerate the development and production of photonics wafers for the AI datacom market. This partnership leverages SCAT's existing MOCVD manufacturing capabilities to increase capacity and reduce dependency on limited InP substrates by utiliz…

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

BlossomHill Therapeutics announced encouraging updated data from its Phase 1/2 SOLARA trial of BH-30643, an investigational OMNI-EGFR inhibitor, in patients with EGFR C797S-positive non-small cell lung cancer (NSCLC). The therapy demonstrated a 45% objective response rate and 88% disease control rate in this difficult-to-treat population, along wit…

Bread Financial Provides Performance Update for August 2026

Bread Financial Provides Performance Update for August 2026

Bread Financial Holdings, Inc. provided its August 2026 performance update showing a 5.6% year-over-year increase in average credit card and other loans and an improvement in credit quality metrics, including a decline in net principal loss rate to 6.40% from 7.57% and a lower delinquency rate of 5.36% compared to 5.84% last year. The company conti…

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Quantum-Si Incorporated announced a significant milestone in protein sequencing technology by demonstrating the ability to detect 18 amino acids using their Proteus™ developmental sequencing kit. The company maintains confidence in achieving detection of all 20 amino acids by the end of 2026, enhancing their product launch prospects for this innova…

GeoPark Limited Announces Commencement of Consent Solicitation with Respect to Its 8.750% Senior Notes Due 2030

GeoPark Limited Announces Commencement of Consent Solicitation with Respect to Its 8.750% Senior Notes Due 2030

GeoPark Limited announced a consent solicitation for its 8.750% Senior Notes due 2030 to amend the indenture definition of "Permitted Holders" to include major shareholder Jaime Gilinski Bacal and his affiliates. This move relates to Grupo Gilinski's recent significant share acquisition and their lead role in GeoPark's planned entry into Venezuela …

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation

Connect Biopharma announced positive topline data from its global Phase 2 Seabreeze STAT Asthma study evaluating rademikibart, an anti-IL-4Rα antibody, as an add-on treatment for acute exacerbations in adult and adolescent asthma patients with type 2 inflammation. The study demonstrated a 66% reduction in treatment failure rate at 28 days (though n…